Cytokeratin 18 Antibody, anti-human, REAdye_lease™
Synonyms: KRT18, CK-18, Keratin-18, K18
RECOMBINANT
Clone:
REAL685
Type of antibody:
Releasable fluorochromes, Primary antibodies, Recombinant antibodies
Applications:
MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:

Related products for Cytokeratin 18 Antibody, anti-human, REAdye_lease™

MICS (MACSima Imaging Cyclic Staining) applications
PE
Vio B515
Vio R667
Fixation:
frozen – Acetone
Species tested:
human
Tissue used:
liver
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
PE
Used products:
130-125-030
Testing grade:
Description:
Immunofluorescence analysis of a human liver cryosection fixed with ice-cold acetone. The section was stained using Cytokeratin 18 Antibody, anti-human, PE (green) for 10 min at room temperature (A). Cytokeratin 18 Antibody, anti-human, PE staining was released using the REAlease Release Reagent (B). Nuclei were visualized with Hoechst™ (blue). Scale bar: 30 µm.

A

Application imageView details view details

B

Application imageView details view details
Fixation:
frozen – PFA
Species tested:
human
Tissue used:
liver
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
PE
Used products:
130-125-030
Testing grade:
Description:
Immunofluorescence analysis of a human liver cryosection fixed with 4% PFA. The section was stained using Cytokeratin 18 Antibody, anti-human, PE (green) for 10 min at room temperature (A). Cytokeratin 18 Antibody, anti-human, PE staining was released using the REAlease Release Reagent (B). Nuclei were visualized with Hoechst™ (blue). Scale bar: 30 µm.

A

Application imageView details view details

B

Application imageView details view details
Specifications for Cytokeratin 18 Antibody, anti-human, REAdye_lease™
Overview

Clone REAL685 is an antibody fragment derived from the full Cytokeratin 18 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity.

Clone REAL685 specifically recognizes cytokeratin 18 (K18). Cytokeratins are located in the intracytoplasmic cytoskeleton of epithelial tissue. Cytokeratin 18 is frequently used in conjunction with keratin 8 and keratin 19 to differentiate cells of epithelial origin from hematopoietic cells and to enumerate circulating tumor cells in blood. Gene mutations of Keratin 18 lead in cryptogenic cirrhosis.

For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675)

Alternative names

KRT18, CK-18, Keratin-18, K18

Detailed product information

Technical specifications

Clone
REAL685
Clonality
monoclonal
Isotype control
Control Antibody
Host
cell line
Type of antibody
Releasable fluorochromes, Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
Cytokeratin 18
Distribution of antigen
epithelial cells, tumor cells, other, colon, placenta, liver
RRID
AB_2905178

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for Cytokeratin 18 Antibody, anti-human, REAdye_lease™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for Cytokeratin 18 Antibody, anti-human, REAdye_lease™
Publications
  1. Oshima, R. G. et al. (1986) Comparison of mouse and human keratin 18: a component of intermediate filaments expressed prior to implantation. Differentiation 33 (1): 61-68
  2. Ku, N. O. et al. (2003) Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. Proc. Natl. Acad. Sci. U.S.A. 100 (10): 6063-6068
  3. Waseem, A. et al. (1990) Embryonic simple epithelial keratins 8 and 18: chromosomal location emphasizes difference from other keratin pairs. New Biol. 2 (5): 464-478